Skip to main content

Table 2 Comparison of the response and relapse rate of the p190 and p210 patients

From: Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era

  p190 p210 p-value
CR1 rate (%) 90.1% (154/171) 91.0% (81/89) 0.805
CMR rate (%)
1 month 22% (29/132) 9.9% (7/71) 0.031
3 months 43.2% (54/125) 41.4% (29/70) 0.810
MMR rate (%)
1 month 37.9% (50/132) 28.2% (20/71) 0.165
3 months 66.4% (83/125) 61.4% (43/70) 0.486
Relapse rate (%) 33.1% (46/139) 29.3% (22/75) 0.573
  1. CR complete remission, CMR complete molecular remission, MMR major molecular remission